Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $206.37 in the prior trading day, Johnson & Johnson (NYSE: JNJ) closed at $207.32, up 0.46%. In other words, the price has increased by $0.46 from its previous closing price. On the day, 7.62 million shares were traded. JNJ stock price reached its highest trading level at $208.08 during the session, while it also had its lowest trading level at $205.5.
Ratios:
Our goal is to gain a better understanding of JNJ by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.49. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In the most recent recommendation for this company, Scotiabank on November 13, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $230.
On October 20, 2025, Daiwa Securities Upgraded its rating to Outperform which previously was Neutral but kept the price unchanged to $203.
Wells Fargo Upgraded its Equal Weight to Overweight on October 03, 2025, while the target price for the stock was maintained at $212.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 26 ’25 when MORIKIS JOHN G bought 1,250 shares for $206.15 per share. The transaction valued at 257,688 led to the insider holds 1,849 shares of the business.
JOHNSON & JOHNSON sold 6,337 shares of JNJ for $63,560 on Nov 26 ’25. The 10% Owner now owns 4,040,861 shares after completing the transaction at $10.03 per share. On Nov 24 ’25, another insider, JOHNSON & JOHNSON, who serves as the 10% Owner of the company, sold 2,200 shares for $10.06 each. As a result, the insider received 22,132 and left with 4,047,198 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JNJ now has a Market Capitalization of 499495075840 and an Enterprise Value of 526728069120. As of this moment, Johnson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.01, and their Forward P/E ratio for the next fiscal year is 17.97. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.42 while its Price-to-Book (P/B) ratio in mrq is 6.29. Its current Enterprise Value per Revenue stands at 5.716 whereas that against EBITDA is 16.5.
Stock Price History:
The Beta on a monthly basis for JNJ is 0.33, which has changed by 0.4149469 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, JNJ has reached a high of $215.18, while it has fallen to a 52-week low of $140.68. The 50-Day Moving Average of the stock is 4.66%, while the 200-Day Moving Average is calculated to be 20.09%.
Shares Statistics:
The stock has traded on average 8.95M shares per day over the past 3-months and 10200360 shares per day over the last 10 days, according to various share statistics. A total of 2.41B shares are outstanding, with a floating share count of 2.41B. Insiders hold about 0.12% of the company’s shares, while institutions hold 74.48% stake in the company. Shares short for JNJ as of 1764288000 were 23910602 with a Short Ratio of 2.67, compared to 1761868800 on 19529775. Therefore, it implies a Short% of Shares Outstanding of 23910602 and a Short% of Float of 0.9900000000000001.
Dividends & Splits
In the trailing 12 months, JNJ’s forward annual dividend rate was 5.08, compared to 5.14 this year. Against a Trailing Annual Dividend Yield of 0.02461598. The stock’s 5-year Average Dividend Yield is 2.79. The current Payout Ratio is 84.80% for JNJ, which recently paid a dividend on 2025-11-25 with an ex-dividend date of 2025-11-25. Stock splits for the company last occurred on 2001-06-13 when the company split stock in a 2:1 ratio.
Earnings Estimates
. The current assessment of Johnson & Johnson (JNJ) involves the perspectives of 18.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $2.75, with high estimates of $2.87 and low estimates of $2.63.
Analysts are recommending an EPS of between $10.96 and $10.77 for the fiscal current year, implying an average EPS of $10.87. EPS for the following year is $11.54, with 26.0 analysts recommending between $12.08 and $11.11.
Revenue Estimates
16 analysts predict $24.14B in revenue for. The current quarter. It ranges from a high estimate of $24.48B to a low estimate of $23.88B. As of. The current estimate, Johnson & Johnson’s year-ago sales were $22.52BFor the next quarter, 16 analysts are estimating revenue of $22.99B. There is a high estimate of $23.28B for the next quarter, whereas the lowest estimate is $22.26B.
A total of 22 analysts have provided revenue estimates for JNJ’s current fiscal year. The highest revenue estimate was $94.05B, while the lowest revenue estimate was $93.42B, resulting in an average revenue estimate of $93.76B. In the same quarter a year ago, actual revenue was $88.82BBased on 24 analysts’ estimates, the company’s revenue will be $98.52B in the next fiscal year. The high estimate is $100.3B and the low estimate is $95.16B.
